KALA KALA BIO, Inc. Common Stock PHARMACEUTICAL PREPARATIONS Best Pharmaceutical Stocks 2026 →

KALA BIO (KALA) Stock: Buy, Sell, or Hold?

$0.16
-0.01 (-5.85%) â–ŧ
5d: +5.57% 30d: -14.36% 90d: -82.97%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (53%)
Quality Score
44/100
Position
SLIGHTLY LOW
30-Day Fair Range
$0.15 – $0.27
Position: SLIGHTLY LOW
Forward P/E & Valuation
-0.3x
Next 12M consensus est.
Wall Street Target
$1.50
+831.7% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$0.15 / $0.19
Trend: Downtrend
💡Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
â„šī¸ NEUTRAL: KALA is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.

Get Alerted When KALA Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

In-depth Analysis How we analyze

Valuation Analysis: KALA is currently trading at $0.16, which is considered slightly low relative to its 30-day fair value range of $0.15 to $0.27.

Technical Outlook: Technically, KALA is in a downtrend. Immediate support is located at $0.15, while resistance sits at $0.19. Short-term momentum is weak, with the stock down 5.8% recently.

Market Sentiment: KALA scores 35/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $1.50 (+831.7%). Current signals suggest waiting for a better entry point before initiating new positions.

Quick Decision Summary

Current Position SLIGHTLY LOW
Historical Trading Range $0.15 - $0.27
Company Quality Score 44/100 (HOLD)
Volume Confirmation HIGH
Confidence Score 52.6%

Trading Range & Key Levels

30-Day Trading Range $0.15 - $0.27
Current vs Trading Range SLIGHTLY LOW
Support Level $0.15
Resistance Level $0.19
Current Trend Downtrend
Technical data as of Nov 12, 2026

Quantitative Signal Breakdown

  • BULLISH: Price oversold vs 30-day range
  • BEARISH: Weak technical setup (35/100)
  • BULLISH: High volume confirmation
  • BEARISH: Downward momentum (-5.8%)
  • BULLISH: Trading 831.7% below Wall St target ($1.50)
  • WARNING: Composite score 44/100 in the bottom quintile — this cohort historically lags the market

Fundamental Context

Forward P/E (Next Year Est.) -0.30
Wall Street Target $1.50 (+831.7%)
Revenue Growth (YoY) -100.0%
Share KALA Analysis

Share this live KALA analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.

bloggers & journalists: you are free to use our charts with attribution.

Reddit & Retail Trader Sentiment (KALA)

Bullish 2 Retail Mentions
Reddit / WSB Comments
1
Bearish
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Nov 10, 2026
Daily AI digest
AI Retail Discussion Summary: KALA Bio reported a significant reduction in quarterly net loss in the preliminary third quarter 2026 financial results. The company also provided a CEO update.
Key Retail Themes: Reduction in quarterly net loss CEO update
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams. View All Trending Reddit & WSB Stocks →
Last updated: November 12, 2026 7:11 PM ET
Data refreshes hourly during market hours. Next update: 8:11 PM
đŸ”Ĩ Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Technical Signals Check
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL

Unlock Insider Activity

See real-time buying/selling by company executives for KALA.

Create Free Account

Already have an account? Log In

Top Rated Biotechnology Stocks

Top-rated stocks in Biotechnology by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
CYTK
Cytokinetics Inc
STRONG BUY
22 analysts
$107 65 BUY
INSM
Insmed Inc
STRONG BUY
24 analysts
$194 37 SELL
MDGL
Madrigal Pharmaceuticalsâ€Ļ
STRONG BUY
19 analysts
$689 58 HOLD
ORIC
Oric Pharmaceuticals Inc
STRONG BUY
15 analysts
$22 67 BUY
CRNX
Crinetics Pharmaceuticalâ€Ļ
STRONG BUY
17 analysts
$86 46 HOLD

Explore More Analysis & Live Quant Tools

Part A: Deep-Dive KALA Research Pages
KALA Technical Chart KALA Price Prediction KALA Intrinsic Value DCF KALA Earnings Date KALA Investment Advisor KALA Fair Price Analyzer KALA Competitors
Part B: Tradestie Flagship Market Scanners
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals